3 Feb 2023 18:08
FORM 8.3 Amendment to Sale | |||||||
IRISH TAKEOVER PANEL | |||||||
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, | |||||||
TAKEOVER RULES, 2007 (AS AMENDED) | |||||||
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES | |||||||
REPRESENTING 1% OR MORE | |||||||
1. | KEY INFORMATION | ||||||
Name of person dealing (Note 1) | Barclays PLC. | ||||||
Company dealt in | HORIZON THERAPEUTICS PLC | ||||||
Class of relevant security to which the | $0.0001 ordinary shares | ||||||
dealings being disclosed relate (Note 2) | |||||||
Date of dealing | 30 January 2023 | ||||||
2. | INTERESTS AND SHORT POSITIONS | ||||||
(a) | Interests and short positions (following dealing) in the class of relevant security | ||||||
| dealt in (Note 3) |
| |||||
Class of relevant security: | $0.0001 ordinary shares | ||||||
Long | Short | ||||||
Number | (%) | Number | (%) | ||||
(1) | Relevant securities | 1,642,536 | 0.72% | 117,657 | 0.05% | ||
(2) | Derivatives (other than options): | 54,280 | 0.02% | 0 | 0.00% | ||
(3) | Options and agreements to | ||||||
purchase/sell: | 251,800 | 0.11% | 25,000 | 0.01% | |||
TOTAL: | |||||||
1,948,616 | 0.85% | 142,657 | 0.06% | ||||
(b) | Interests and short positions in relevant securities of the company, | ||||||
| other than the class dealt in |
| |||||
Class of relevant security: | Long | Short | |||||
Number | (%) | Number | (%) | ||||
(1) | Relevant securities | ||||||
(2) | Derivatives (other than options): | ||||||
(3) | Options and agreements to | ||||||
purchase/sell: | |||||||
TOTAL: | |||||||
3. | DEALINGS (Note 4) | ||||||
(a) | Purchases and sales | ||||||
Purchase/sale | Purchase/sale | Number of relevant securities | Price per unit | ||||
$0.0001 ordinary shares | Purchase | 1 | 110.4000 USD | ||||
$0.0001 ordinary shares | Purchase | 2 | 110.7250 USD | ||||
$0.0001 ordinary shares | Purchase | 2 | 110.4900 USD | ||||
$0.0001 ordinary shares | Purchase | 3 | 110.5666 USD | ||||
$0.0001 ordinary shares | Purchase | 4 | 110.6450 USD | ||||
$0.0001 ordinary shares | Purchase | 6 | 110.3550 USD | ||||
$0.0001 ordinary shares | Purchase | 6 | 110.4333 USD | ||||
$0.0001 ordinary shares | Purchase | 71 | 110.5300 USD | ||||
$0.0001 ordinary shares | Purchase | 100 | 110.5200 USD | ||||
$0.0001 ordinary shares | Purchase | 100 | 110.6700 USD | ||||
$0.0001 ordinary shares | Purchase | 100 | 110.5100 USD | ||||
$0.0001 ordinary shares | Purchase | 100 | 110.1500 USD | ||||
$0.0001 ordinary shares | Purchase | 101 | 110.4700 USD | ||||
$0.0001 ordinary shares | Purchase | 172 | 110.1483 USD | ||||
$0.0001 ordinary shares | Purchase | 174 | 110.4318 USD | ||||
$0.0001 ordinary shares | Purchase | 200 | 110.4850 USD | ||||
$0.0001 ordinary shares | Purchase | 200 | 110.3750 USD | ||||
$0.0001 ordinary shares | Purchase | 200 | 110.3700 USD | ||||
$0.0001 ordinary shares | Purchase | 200 | 110.5150 USD | ||||
$0.0001 ordinary shares | Purchase | 202 | 110.4250 USD | ||||
$0.0001 ordinary shares | Purchase | 300 | 110.3066 USD | ||||
$0.0001 ordinary shares | Purchase | 300 | 110.5366 USD | ||||
$0.0001 ordinary shares | Purchase | 300 | 110.2966 USD | ||||
$0.0001 ordinary shares | Purchase | 305 | 110.1400 USD | ||||
$0.0001 ordinary shares | Purchase | 500 | 110.4600 USD | ||||
$0.0001 ordinary shares | Purchase | 845 | 110.1442 USD | ||||
$0.0001 ordinary shares | Purchase | 1,000 | 110.2830 USD | ||||
$0.0001 ordinary shares | Purchase | 1,000 | 110.4970 USD | ||||
$0.0001 ordinary shares | Purchase | 1,259 | 110.1494 USD | ||||
$0.0001 ordinary shares | Purchase | 1,302 | 110.1435 USD | ||||
$0.0001 ordinary shares | Purchase | 1,400 | 110.3106 USD | ||||
$0.0001 ordinary shares | Purchase | 1,400 | 110.1778 USD | ||||
$0.0001 ordinary shares | Purchase | 1,469 | 110.1446 USD | ||||
$0.0001 ordinary shares | Purchase | 1,506 | 110.2865 USD | ||||
$0.0001 ordinary shares | Purchase | 1,518 | 110.1365 USD | ||||
$0.0001 ordinary shares | Purchase | 1,623 | 110.2325 USD | ||||
$0.0001 ordinary shares | Purchase | 1,700 | 110.3371 USD | ||||
$0.0001 ordinary shares | Purchase | 1,718 | 110.2868 USD | ||||
$0.0001 ordinary shares | Purchase | 1,751 | 110.1369 USD | ||||
$0.0001 ordinary shares | Purchase | 2,089 | 110.1990 USD | ||||
$0.0001 ordinary shares | Purchase | 2,331 | 110.1534 USD | ||||
$0.0001 ordinary shares | Purchase | 3,152 | 110.2631 USD | ||||
$0.0001 ordinary shares | Purchase | 3,417 | 110.5000 USD | ||||
$0.0001 ordinary shares | Purchase | 3,744 | 110.2693 USD | ||||
$0.0001 ordinary shares | Purchase | 4,112 | 110.1351 USD | ||||
$0.0001 ordinary shares | Purchase | 5,078 | 110.1443 USD | ||||
$0.0001 ordinary shares | Purchase | 5,183 | 110.3859 USD | ||||
$0.0001 ordinary shares | Purchase | 5,522 | 110.3343 USD | ||||
$0.0001 ordinary shares | Purchase | 6,818 | 110.2849 USD | ||||
$0.0001 ordinary shares | Purchase | 7,125 | 110.2696 USD | ||||
$0.0001 ordinary shares | Purchase | 7,131 | 110.3209 USD | ||||
$0.0001 ordinary shares | Purchase | 8,156 | 110.4965 USD | ||||
$0.0001 ordinary shares | Purchase | 8,815 | 110.3492 USD | ||||
$0.0001 ordinary shares | Purchase | 9,050 | 110.2388 USD | ||||
$0.0001 ordinary shares | Purchase | 9,523 | 110.1280 USD | ||||
$0.0001 ordinary shares | Purchase | 10,437 | 110.0891 USD | ||||
$0.0001 ordinary shares | Purchase | 11,397 | 110.1428 USD | ||||
$0.0001 ordinary shares | Purchase | 11,912 | 110.2978 USD | ||||
$0.0001 ordinary shares | Purchase | 17,581 | 110.1491 USD | ||||
$0.0001 ordinary shares | Purchase | 23,397 | 110.3509 USD | ||||
$0.0001 ordinary shares | Purchase | 23,888 | 110.1560 USD | ||||
$0.0001 ordinary shares | Purchase | 42,431 | 110.3622 USD | ||||
$0.0001 ordinary shares | Purchase | 46,303 | 110.0500 USD | ||||
$0.0001 ordinary shares | Purchase | 49,542 | 110.1713 USD | ||||
$0.0001 ordinary shares | Purchase | 67,920 | 110.2942 USD | ||||
$0.0001 ordinary shares | Purchase | 77,197 | 110.3002 USD | ||||
$0.0001 ordinary shares | Purchase | 352,217 | 110.4741 USD | ||||
$0.0001 ordinary shares | Purchase | 436,430 | 110.3648 USD | ||||
$0.0001 ordinary shares | Purchase | 528,174 | 110.1317 USD | ||||
$0.0001 ordinary shares | Purchase | 1,559,339 | 110.3053 USD | ||||
$0.0001 ordinary shares | Sale | 25 | 110.1500 USD | ||||
$0.0001 ordinary shares | Sale | 100 | 110.1400 USD | ||||
$0.0001 ordinary shares | Sale | 200 | 110.5450 USD | ||||
$0.0001 ordinary shares | Sale | 200 | 110.4395 USD | ||||
$0.0001 ordinary shares | Sale | 205 | 110.6800 USD | ||||
$0.0001 ordinary shares | Sale | 300 | 110.6833 USD | ||||
$0.0001 ordinary shares | Sale | 400 | 110.4100 USD | ||||
$0.0001 ordinary shares | Sale | 440 | 110.4534 USD | ||||
$0.0001 ordinary shares | Sale | 446 | 110.4615 USD | ||||
$0.0001 ordinary shares | Sale | 475 | 110.5000 USD | ||||
$0.0001 ordinary shares | Sale | 475 | 110.5857 USD | ||||
$0.0001 ordinary shares | Sale | 481 | 110.1656 USD | ||||
$0.0001 ordinary shares | Sale | 600 | 110.5983 USD | ||||
$0.0001 ordinary shares | Sale | 600 | 110.3208 USD | ||||
$0.0001 ordinary shares | Sale | 802 | 110.4586 USD | ||||
$0.0001 ordinary shares | Sale | 962 | 110.2893 USD | ||||
$0.0001 ordinary shares | Sale | 1,000 | 110.2390 USD | ||||
$0.0001 ordinary shares | Sale | 1,097 | 110.2707 USD | ||||
$0.0001 ordinary shares | Sale | 1,400 | 110.5089 USD | ||||
$0.0001 ordinary shares | Sale | 1,565 | 110.4184 USD | ||||
$0.0001 ordinary shares | Sale | 1,900 | 110.5552 USD | ||||
$0.0001 ordinary shares | Sale | 1,926 | 110.5707 USD | ||||
$0.0001 ordinary shares | Sale | 2,419 | 110.1949 USD | ||||
$0.0001 ordinary shares | Sale | 2,574 | 110.1267 USD | ||||
$0.0001 ordinary shares | Sale | 3,237 | 110.1994 USD | ||||
$0.0001 ordinary shares | Sale | 3,271 | 110.2612 USD | ||||
$0.0001 ordinary shares | Sale | 3,356 | 110.3458 USD | ||||
$0.0001 ordinary shares | Sale | 3,464 | 110.1475 USD | ||||
$0.0001 ordinary shares | Sale | 4,783 | 110.1737 USD | ||||
$0.0001 ordinary shares | Sale | 5,238 | 110.4471 USD | ||||
$0.0001 ordinary shares | Sale | 6,558 | 110.1010 USD | ||||
$0.0001 ordinary shares | Sale | 6,887 | 110.4207 USD | ||||
$0.0001 ordinary shares | Sale | 6,972 | 110.5677 USD | ||||
$0.0001 ordinary shares | Sale | 7,703 | 110.1030 USD | ||||
$0.0001 ordinary shares | Sale | 8,307 | 110.3364 USD | ||||
$0.0001 ordinary shares | Sale | 8,322 | 110.4817 USD | ||||
$0.0001 ordinary shares | Sale | 9,987 | 110.2210 USD | ||||
$0.0001 ordinary shares | Sale | 18,624 | 110.1933 USD | ||||
$0.0001 ordinary shares | Sale | 28,859 | 110.1872 USD | ||||
$0.0001 ordinary shares | Sale | 30,323 | 110.4073 USD | ||||
$0.0001 ordinary shares | Sale | 34,855 | 110.2127 USD | ||||
$0.0001 ordinary shares | Sale | 35,866 | 110.2007 USD | ||||
$0.0001 ordinary shares | Sale | 47,000 | 110.1848 USD | ||||
$0.0001 ordinary shares | Sale | 51,015 | 110.3407 USD | ||||
$0.0001 ordinary shares | Sale | 62,939 | 110.2881 USD | ||||
$0.0001 ordinary shares | Sale | 65,878 | 110.1461 USD | ||||
$0.0001 ordinary shares | Sale | 76,295 | 110.0500 USD | ||||
$0.0001 ordinary shares | Sale | 90,081 | 110.6208 USD | ||||
$0.0001 ordinary shares | Sale | 100,000 | 110.4875 USD | ||||
$0.0001 ordinary shares | Sale | 146,603 | 110.2960 USD | ||||
$0.0001 ordinary shares | Sale | 169,887 | 110.1838 USD | ||||
$0.0001 ordinary shares | Sale | 249,022 | 110.3697 USD | ||||
$0.0001 ordinary shares | Sale | 393,707 | 110.3300 USD | ||||
$0.0001 ordinary shares | Sale | 527,941 | 110.2544 USD | ||||
$0.0001 ordinary shares | Sale | 554,925 | 110.4236 USD | ||||
$0.0001 ordinary shares | Sale | 587,336 | 110.1465 USD | ||||
(b) | Derivatives transactions (other than options) |
| |||||
Product Name | Nature of transaction | Number of relevant securities | Price per unit | ||||
(c) | Options transactions in respect of existing securities |
| |||||
(i) | Writing, selling, purchasing or varying |
| |||||
Class | Product | Writing, | Number | Exercise | Type | Expiry | Option |
of | description | purchasing, | of | price | date | money | |
relevant | selling, | securities | per unit | paid/ | |||
security | varying etc | to which | received | ||||
option | per unit | ||||||
relates | |||||||
(ii) | Exercising |
| |||||
Product name | Number of | Exercise price per | |||||
securities | unit | ||||||
(d) | Other dealings (including transactions in respect of new securities) (Note 4) | ||||||
Nature of transaction | Details | Price per unit (if | |||||
applicable) | |||||||
4. | OTHER INFORMATION | ||||||
Agreements, arrangements or understandings relating to options or derivatives |
| ||||||
Full details of any agreement, arrangement or understanding between the person disclosing | |||||||
and any other person relating to the voting rights of any relevant securities under any option | |||||||
referred to on this form or relating to the voting rights or future acquisition or disposal of any | |||||||
relevant securities to which any derivative referred to on this form is referenced. If none, this | |||||||
should be stated. | |||||||
NONE | |||||||
Is a Supplemental Form 8 (Open Positions) attached? | YES | ||||||
Date of disclosure: | 3 Feb 2023 | ||||||
Contact name: | Large Holdings Regulatory Operations | ||||||
Telephone number: | 020 3134 7213 | ||||||
If a connected EFM, name of offeree/offeror with which connected | |||||||
If a connected EFM, state nature of connection | |||||||
SUPPLEMENTAL FORM 8 | |||||||
IRISH TAKEOVER PANEL | |||||||
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL | |||||||
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) | |||||||
DETAILS OF OPEN POSITIONS | |||||||
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as | |||||||
appropriate) | |||||||
OPEN POSITIONS | |||||||
| Product name | Written or | Number of | Exercise | Type | Expiry | |
purchased | relevant securities | price | date | ||||
to which the option | |||||||
or derivative | |||||||
relates | |||||||
$0.0001 ordinary shares | Put Options | Written | 151,800 | 85.0000 | American | Feb 17, 2023 | |
$0.0001 ordinary shares | Put Options | Written | 100,000 | 90.0000 | American | May 19, 2023 | |
$0.0001 ordinary shares | Put Options | Purchased | -25,000 | 85.0000 | American | May 19, 2023 |